The tumor size decreased from 117 mm3 to 20.8 mm3 and 2.6 mm3 upon treatment with LHRH-NLC- paclitaxel, and LHRH-NLC- paclitaxel -siRNAs, respectively. This evidence concerns the gene GNRH1 and neoplasm.